A new study compared BAL cell-free DNA (cfDNA) sequencing against plasma cell-free BAL sequencing to detect lung cancer-derived mutations. The BAL cfDNA approach detected ≥1 tumor-derived mutation in ...
Tissue-based comprehensive genomic profiling (CGP) is increasingly used for treatment selection in patients with advanced cancer; however, tissue availability may limit widespread implementation. Here ...
Robust methods for deep-scale enrichment and site-specific identification of ubiquitylation sites is necessary for characterizing the myriad roles of protein ubiquitylation. UbiFast is a highly ...
Characterization of Non–Small-Cell Lung Cancers With MET Exon 14 Skipping Alterations Detected in Tissue or Liquid: Clinicogenomics and Real-World Treatment Patterns Among 31,165 (97.2%) samples where ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results